4//SEC Filing
SCHULMAN AMY W 4
Accession 0001735276-25-000037
CIK 0001178670other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:16 PM ET
Size
7.0 KB
Accession
0001735276-25-000037
Insider Transaction Report
Form 4
SCHULMAN AMY W
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-13$131.21/sh+2,750$360,828→ 11,186 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-13−2,750→ 0 totalExercise: $131.21From: 2016-06-01Exp: 2025-06-01→ Common Stock (2,750 underlying)
Footnotes (2)
- [F1]The options exercised and held by the reporting person were due to expire on June 1, 2025.
- [F2]The stock option was fully vested as of June 1, 2016.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001438226
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:16 PM ET
- Size
- 7.0 KB